Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127896551 | 12789655 | 1 | I | 20150824 | 20160921 | 20160928 | 20160928 | EXP | JP-MYLANLABS-2016M1040959 | MYLAN | 0.00 | Y | 0.00000 | 20160928 | OT | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127896551 | 12789655 | 1 | PS | Cilostazol MYLAN | CILOSTAZOL | 1 | Oral | 50 MG, BID | D | 77019 | 50 | MG | TABLET | BID | |||||
127896551 | 12789655 | 2 | SS | Magnesium Oxide MYLAN | MAGNESIUM OXIDE | 1 | Oral | 500 MG, BID | D | 0 | 500 | MG | TABLET | BID | |||||
127896551 | 12789655 | 3 | SS | ELIQUIS | APIXABAN | 1 | Oral | 2.5 MG, BID | D | 0 | 2.5 | MG | TABLET | BID | |||||
127896551 | 12789655 | 4 | SS | ELIQUIS | APIXABAN | 1 | D | 0 | TABLET | ||||||||||
127896551 | 12789655 | 5 | SS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, QD | D | 0 | 5 | MG | TABLET | QD | |||||
127896551 | 12789655 | 6 | SS | MECOBALAMIN | METHYLCOBALAMIN | 1 | Oral | 500 ?G, TID | D | 0 | 500 | UG | TABLET | TID | |||||
127896551 | 12789655 | 7 | SS | LIMAPROST ALFADEX | LIMAPROST | 1 | Oral | 5 ?G, TID | D | 0 | 5 | UG | TABLET | TID | |||||
127896551 | 12789655 | 8 | SS | AZOSEMIDE | AZOSEMIDE | 1 | Oral | 15 MG, QD | D | 0 | 15 | MG | TABLET | QD | |||||
127896551 | 12789655 | 9 | SS | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 100 MG, BID | D | 0 | 100 | MG | TABLET | BID | |||||
127896551 | 12789655 | 10 | SS | PREGABALIN. | PREGABALIN | 1 | Oral | 150 MG, BID | D | 0 | 150 | MG | CAPSULE | BID | |||||
127896551 | 12789655 | 11 | SS | WARFARIN POTASSIUM | WARFARIN POTASSIUM | 1 | Oral | 2 MG, QD | D | 0 | 2 | MG | TABLET | QD | |||||
127896551 | 12789655 | 12 | SS | WARFARIN POTASSIUM | WARFARIN POTASSIUM | 1 | Oral | 2 MG, QD | D | 0 | 2 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127896551 | 12789655 | 1 | Lumbar spinal stenosis |
127896551 | 12789655 | 2 | Constipation |
127896551 | 12789655 | 3 | Ischaemic stroke |
127896551 | 12789655 | 4 | Embolism |
127896551 | 12789655 | 5 | Hypertension |
127896551 | 12789655 | 6 | Lumbar spinal stenosis |
127896551 | 12789655 | 7 | Lumbar spinal stenosis |
127896551 | 12789655 | 8 | Oedema |
127896551 | 12789655 | 9 | Hyperuricaemia |
127896551 | 12789655 | 10 | Lumbar spinal stenosis |
127896551 | 12789655 | 11 | Atrial fibrillation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127896551 | 12789655 | OT |
127896551 | 12789655 | DE |
127896551 | 12789655 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127896551 | 12789655 | Cardiac failure congestive | |
127896551 | 12789655 | Cardiac valve disease | |
127896551 | 12789655 | Ear haemorrhage | |
127896551 | 12789655 | Haematemesis | |
127896551 | 12789655 | Haemorrhagic diathesis | |
127896551 | 12789655 | Heart valve stenosis | |
127896551 | 12789655 | International normalised ratio increased | |
127896551 | 12789655 | Interstitial lung disease | |
127896551 | 12789655 | Right ventricular failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127896551 | 12789655 | 3 | 20151001 | 0 | ||
127896551 | 12789655 | 11 | 20150924 | 0 | ||
127896551 | 12789655 | 12 | 20151001 | 0 |